Loading your page…

Pharmaceutical group

Idorsia

15 medicines6 countries

A group of 4 companies with 15 medicines in 6 countries.

Its medicines

Group structure

4 companies in 3 countries

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

15 medicines

Medicine	Substance	Country	Status	Authorised
Jeraygo	Aprocitentan	EU (EMA)	Authorised
JERAYGO12.5 mg · Tablet	Aprocitentan	Canada	Authorised
JERAYGO25 mg · Tablet	Aprocitentan	Canada	Authorised
JERAYGO 12,5 mg filmomhulde tablettenFilmomhulde tablet	Aprocitentan	Netherlands	Authorised	2024
JERAYGO 25 mg filmomhulde tablettenFilmomhulde tablet	Aprocitentan	Netherlands	Authorised	2024
QUVIVIQ25mg base \| 50mg base · Tablet	Daridorexant	United States	Marketed	2022
Quviviq	Daridorexant	EU (EMA)	Authorised	2022
QUVIVIQCompressa rivestita con film	Daridorexant	Italy	Authorised
QUVIVIQ50 mg · Tablet	Daridorexant	Canada	Marketed	2023
QUVIVIQ25 mg · Tablet	Daridorexant	Canada	Authorised
QUVIVIQ 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA27,02 mg · Comprimido recubierto con película	Daridorexant	Spain	Marketed	2022
Quviviq 25 mg, filmomhulde tabletFilmomhulde tablet	Daridorexant	Netherlands	Authorised	2022
QUVIVIQ 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA54,04 mg · Comprimido recubierto con película	Daridorexant	Spain	Marketed	2022
Quviviq 50 mg, filmomhulde tabletFilmomhulde tablet	Daridorexant	Netherlands	Authorised	2022
TRYVIO12.5mg · Tablet	Aprocitentan	United States	Marketed	2024

Sources and licences

Country	Medicines	Current	Companies
Canada	4	4	Companies All medicines
Netherlands	4	4	Companies All medicines
Spain	2	2	Companies All medicines
European Union (EMA)	2	2	Companies All medicines
United States	2	2	Companies All medicines
Italy	1	1	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

All 12 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Report an error or request removalCorrections from the company itself are welcome.

Idorsia

Group structure

Germany1

Spain1

United States1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Idorsia

Group structure

Germany1

Spain1

United States1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇩🇪Germany1

🇪🇸Spain1

🇺🇸United States1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Group structure

🇩🇪Germany1

🇪🇸Spain1

🇺🇸United States1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Germany1

Spain1

United States1

Germany1

Spain1

United States1